Vertex Stock Hits Record High on Phase 2 Study Results and Gene-Editing Deal
Vertex Pharmaceuticals shares hit a record high after the results of a pain medicine study and announcing a gene-editing technology agreement.
Stay updated with breaking news from Stroy Freeman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vertex Pharmaceuticals shares hit a record high after the results of a pain medicine study and announcing a gene-editing technology agreement.
According to AAA, Louisiana is among the nation's top, 10, least expensive oil markets. As a result, some travelers are encouraging drivers to take advantage of the reduced gas prices.
Plus: Tory By-election blues; HMRC harassment; straw bale farce; carol culture; and not being Welsh
Theravance Biopharma Inc. (NASDAQ: TBPH)’s stock price has increased by 3.05 compared to its previous closing price of 9.52. However, the company has seen a 3.81% increase in its stock price over the last five trading sessions. PRNewsWire reported 2023-08-28 that DUBLIN, Aug. 28, 2023 /PRNewswire/
/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced new ampreloxetine data in neurogenic...